http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102695716-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57469 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate | 2010-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102695716-B |
titleOfInvention | Liver disease index sugar chain marker |
abstract | Problem of the present invention is to provide a kind of sugar chain marker that can detect hepatopathy.Specifically, problem of the present invention is to develop a kind of sugar chain marker that can serve as liver disease index.In addition, problem of the present invention is also to develop and a kind ofly can distinguishes the sugar chain marker of liver disease along with the progress of hepatocellular carcinoma.For seroglycoid, present inventor has identified in the hepatopathy comprising hepatocellular carcinoma, the glycopeptide of its sugar chain structure generation specific variations and the group of sugar-protein, and it can be used as new liver disease specificity (glycopeptide and sugar-protein) sugar chain marker. |
priorityDate | 2009-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 449.